News
Filter
-
MRC Technology launches small molecule compound library access scheme
-
Intellect Neurosciences and MRC Technology announce humanization of next-generation monoclonal antibody to amyloid beta with reduced potential for inflammation in the brain of Alzheimer’s patients
-
New postpartum haemorrhage drug discovery project launched
-
GPCR collaboration with Heptares extended
-
New ACTH-dependent Cushing’s Syndrome drug discovery project launched
-
New drug discovery collaborations with Queen Mary University of London launched
-
MRCT announce second drug discovery collaboration with University of Bristol
-
Mount Sinai School of Medicine and MRC Technology to collaborate on monoclonal antibody production and humanization
-
MRC Technology launches research grant terms approval service
-
Phosphate Therapeutics acquires novel phosphate binder (PT20) from the Medical Research Council and secures development funding from Inventages venture capital for compound’s phase 2 development
-
New drug discovery collaboration with University of Bristol launched
-
New cancer therapeutic antibody project launched
